AccueilOPL • ASX
add
Opyl Ltd
Dernière clôture
0,026 $
Variation sur la journée
0,026 $ - 0,026 $
Plage sur l'année
0,014 $ - 0,033 $
Capitalisation boursière
5,02 M AUD
Volume moyen
147,09 k
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
ASX
Actualités des marchés
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
| (AUD) | déc. 2024info | Variation Y/Y |
|---|---|---|
Chiffre d'affaires | 21,07 k | -82,70 % |
Charges d'exploitation | 176,95 k | -22,08 % |
Résultat net | -341,60 k | 46,47 % |
Marge bénéficiaire nette | -1,62 k | -209,51 % |
Bénéfice par action | — | — |
EBITDA | -318,25 k | 25,33 % |
Taux d'imposition effectif | — | — |
Bilan
Total des actifs
Total du passif
| (AUD) | déc. 2024info | Variation Y/Y |
|---|---|---|
Trésorerie/Invest. court terme | 329,55 k | -43,64 % |
Total des actifs | 384,82 k | -41,63 % |
Total du passif | 695,82 k | -3,76 % |
Total des capitaux propres | -310,99 k | — |
Actions en circulation | 192,86 M | — |
Ratio cours/valeur comptable | ∞ | — |
Rentabilité des actifs | — | — |
Retour sur capitaux | — | — |
Flux de trésorerie
Variation nette en trésorerie
| (AUD) | déc. 2024info | Variation Y/Y |
|---|---|---|
Résultat net | -341,60 k | 46,47 % |
Trésorerie (opérations) | -309,99 k | -6,88 % |
Trésorerie (invest.) | -662,00 | — |
Trésorerie (financement) | 288,10 k | -19,06 % |
Variation nette en trésorerie | -22,55 k | -134,21 % |
Flux de trésorerie dispo. | -200,88 k | 17,96 % |
À propos
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Date de fondation
2013
Site Web
Employés
3
